about
NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicityARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia.Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia.PharmGKB summary: methotrexate pathway.Inherited genetic variation in childhood acute lymphoblastic leukemia.Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcomeRelapse-specific mutations in NT5C2 in childhood acute lymphoblastic leukemiaThiopurine S-methyltransferase pharmacogenetics in childhood acute lymphoblastic leukemia.Preclinical evaluation of NUDT15-guided thiopurine therapy and its effects on toxicity and anti-leukemic efficacy.MYCN drives glutaminolysis in neuroblastoma and confers sensitivity to an ROS augmenting agent.Relapsed acute lymphoblastic leukemia-specific mutations in NT5C2 cluster into hotspots driving intersubunit stimulation.Diplotype analysis of NUDT15 variants and 6-mercaptopurine sensitivity in pediatric lymphoid neoplasmsClinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 UpdateIdentifying IGH disease clones for MRD monitoring in childhood B-cell acute lymphoblastic leukemia using RNA-SeqNovel susceptibility variants at the ERG locus for childhood acute lymphoblastic leukemia in HispanicsSomatic and germline genomics in paediatric acute lymphoblastic leukaemiaPAX5-driven subtypes of B-progenitor acute lymphoblastic leukemiaIdentification of four novel associations for B-cell acute lymphoblastic leukaemia riskGenetic defects in hematopoietic transcription factors and predisposition to acute lymphoblastic leukemia
P50
Q28115755-28571302-E165-434E-A820-8E25F8317CBBQ34250780-4293F97B-0338-4621-986C-4FF7910B7E0BQ35015010-2172DF6B-323D-452C-91C3-4AC721FA9707Q35115680-6990DDCB-4C02-452A-9029-25F6C583C4DAQ35784497-C6E2EAE4-7E73-4303-9C16-AA74F574118EQ35876592-9ECF5F9E-0626-4147-9AC1-C7B51CEE498FQ41911065-02AF5C90-F192-44AE-BA53-8A9C4C71EB07Q46771812-AD8E5EA8-3BD6-4F3C-8824-9532D6278788Q51735726-3D660EE1-C9F1-4DE6-8C9B-D8374F5ABE85Q52694952-CA4CD497-4264-450A-9341-F02F450D0508Q53702261-1F47AC39-518A-4AEF-9B8C-6C4FEB12B5F7Q57518085-77831676-770F-4699-9FE2-759EA665BC10Q64121167-4FCFC924-1B1B-481F-A4CD-B3E018DD03BEQ89882469-D52C984C-3563-4018-BC23-6642FDFDE7CAQ90226917-54FEEC5C-62C4-4640-AFA2-902FD3CBB576Q90463690-8AE1D561-7317-450C-8929-5CFA170CC213Q91045688-9ACEA2F8-4B2D-47B4-8AB5-0BF383790045Q91451448-AEC6E5C4-FD88-41DF-8421-0CFC9AB66790Q91935421-6A44615A-83C1-4AC9-B51E-E424A011ECB2
P50
description
researcher ORCID ID = 0000-0002-0770-9659
@en
name
Jun J Yang
@ast
Jun J Yang
@en
Jun J Yang
@es
Jun J Yang
@nl
type
label
Jun J Yang
@ast
Jun J Yang
@en
Jun J Yang
@es
Jun J Yang
@nl
prefLabel
Jun J Yang
@ast
Jun J Yang
@en
Jun J Yang
@es
Jun J Yang
@nl
P1153
54792597400
P31
P496
0000-0002-0770-9659